BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15301975)

  • 1. Risk of Plasmodium falciparum infection during a malaria epidemic in highland Kenya, 1997.
    John CC; Koech DK; Sumba PO; Ouma JH
    Acta Trop; 2004 Sep; 92(1):55-61. PubMed ID: 15301975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya.
    Terlouw DJ; Aidoo MA; Udhayakumar V; Kolczak MS; Oloo AJ; Kager PA; Lal AA; Nahlen BL; Kuile FO
    J Infect Dis; 2002 Dec; 186(11):1661-8. PubMed ID: 12447744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of Plasmodium falciparum infection among asymptomatic individuals in a highland area of Kenya.
    John CC; McHugh MM; Moormann AM; Sumba PO; Ofulla AV
    Trans R Soc Trop Med Hyg; 2005 Oct; 99(10):780-6. PubMed ID: 16085173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
    Shah SN; Smith EE; Obonyo CO; Kain KC; Bloland PB; Slutsker L; Hamel MJ
    J Infect Dis; 2006 Dec; 194(11):1519-28. PubMed ID: 17083036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
    Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
    Sowunmi A; Fateye BA; Adedeji AA; Gbotosho GO; Happi TC; Bamgboye AE; Bolaji OM; Oduola AM
    Acta Trop; 2006 Apr; 98(1):6-14. PubMed ID: 16513078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia and malaria at different altitudes in the western highlands of Kenya.
    Akhwale WS; Lum JK; Kaneko A; Eto H; Obonyo C; Björkman A; Kobayakawa T
    Acta Trop; 2004 Jul; 91(2):167-75. PubMed ID: 15234666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the parasitologic efficacy of amodiaquine and sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in the Bungoma District of western Kenya.
    Vreugdenhil CJ; Scheper FY; Hoogstraatte SR; Smolders M; Gikunda S; Cobelens FG; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):537-41. PubMed ID: 15569779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
    Mohapatra PK; Prakash A; Taison K; Negmu K; Gohain AC; Namchoom NS; Wange D; Bhattacharyya DR; Goswami BK; Borgohain BK; Mahanta J
    Trop Med Int Health; 2005 May; 10(5):478-83. PubMed ID: 15860095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
    Kobbe R; Kreuzberg C; Adjei S; Thompson B; Langefeld I; Thompson PA; Abruquah HH; Kreuels B; Ayim M; Busch W; Marks F; Amoah K; Opoku E; Meyer CG; Adjei O; May J
    Clin Infect Dis; 2007 Jul; 45(1):16-25. PubMed ID: 17554695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of chloroquine and sulfadoxine/pyrimethamine mono- and combined therapy against falciparum malaria in Sudan.
    Elamin SB; Malik el-FM; Ahmed el-DS; Elabadil EK; Mohamad TA
    East Mediterr Health J; 2007; 13(1):25-34. PubMed ID: 17546902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
    Barnes KI; Little F; Smith PJ; Evans A; Watkins WM; White NJ
    Clin Pharmacol Ther; 2006 Dec; 80(6):582-96. PubMed ID: 17178260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug sensitivity studies during a highland malaria epidemic in Kenya.
    Khan B; Ofulla AV; Kariuki DM; Githure JI; Kabiru EW; Martin SK
    Trans R Soc Trop Med Hyg; 1992; 86(4):371-2. PubMed ID: 1440805
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.